MDC Insider Trading (Medlab Clinical)
Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$36,999.93
Insider Selling (Last 12 Months): A$0.00
Medlab Clinical Share Price & Price History
Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET
Bargain in Today's Market (SHOCKING)
From Oxford Club | Ad
This "World's Most Admired" company's stock would be a bargain at $50...Today it's just $2! Plus... a key May 12 announcement could send it ROCKETING skyward...
Click Here Now (Before It's Too Late!)
>>>
Medlab Clinical Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 4/4/2022 | Sean Hall | Insider | Buy | 109,890 | A$0.09 | A$9,999.99 | | |
| 3/30/2022 | Sean Hall | Insider | Buy | 95,744 | A$0.09 | A$8,999.94 | | |
| 11/4/2021 | Sean Hall | Insider | Buy | 100,000 | A$0.18 | A$18,000.00 | | |
| 10/18/2021 | Cheryl Maley | Insider | Issued | 1,500,000 | A$0.16 | A$240,000.00 | | |
| 11/12/2020 | Drew Townsend | Insider | Issued | 2,000,000 | A$0.19 | A$370,000.00 | | |
| 4/14/2020 | Michael Hall | Insider | Sell | 68,707 | A$0.27 | A$18,619.60 | | |
| 7/1/2019 | Michael Hall | Insider | Exercise | 850,000 | A$0.30 | A$255,000.00 | | |
| 5/23/2019 | Michael Hall | Insider | Sell | 30,000 | A$0.41 | A$12,330.00 | | |
How You Should Be Choosing Your Stocks
From Vantage Point | Ad
Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades.
We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.
Click here now to join and get access to our forecasting.
SEC Filings (Institutional Ownership Changes) for Medlab Clinical (ASX:MDC)
Medlab Clinical Limited, a biotechnology company, researches, develops, and commercializes pharmaceutical and nutraceutical products in Australia. Its lead drug candidate includes NanaBis, an oro-buccal administered equimolar tetrahydrocannabinol (THC) and cannabidiol (CBD) formulation as monotherapy, which is in phase 3 multi-centre, quadruple-blind, randomized- withdrawal active, and placebo-controlled clinical study for the management of opioid-requiring-bone-pain due to metastatic cancer. The company also develops NanoCelle, a patented sub-micron drug delivery platform that enhances drug solubility issues and enables faster absorption and metabolism of active ingredients. In addition, it offers vitamins and supplements; and virtual clinic services. Medlab Clinical Limited was founded in 2012 and is headquartered in Botany, Australia.
Read More on Medlab Clinical
Today's Range
Now: N/A
50 Day Range
MA: N/A
52 Week Range
Now: N/A
Volume
36,677 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Who are the company insiders with the largest holdings of Medlab Clinical?
